Skip to content

Company · founded 2010

Extend Biosciences (United States)

Cambridge, United States · extendbio.com

Manage this page

Citations, last 5 years: 24
Works, last 5 years: 3
h-index: 6
Scientists listed: 0
Grants since 2016: 14

Grants received

2024–2026 · research · R44

Long-acting PTH for hypoparathyroidism

Laura M Hales · Extend Biosciences (United States) · funded by National Institutes of Health

$999.6kThyroid and Parathyroid Surgery

2024–2026 · research · R44

Long-acting PTH for hypoparathyroidism

Laura M Hales · Extend Biosciences (United States) · funded by National Institutes of Health

$999.6k

2023–2028 · research · R01

A Phase 2 Study Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults with Hypoparathyroidism (IND146180; October 14, 2022)

Laura M Hales · Extend Biosciences (United States) · funded by U.S. Food and Drug Administration

$899.8k

2023–2028 · research · R01

A Phase 2 Study Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults with Hypoparathyroidism (IND146180; October 14, 2022)

Laura M Hales · Extend Biosciences (United States) · funded by U.S. Food and Drug Administration

$899.8k

2019–2021 · research · R43

Long-acting ghrelin for neuropathy

Tarik Soliman · Extend Biosciences (United States) · funded by National Institutes of Health

$535.3kRegulation of Appetite and Obesity

2017–2019 · research · R43

Long-acting ghrelin for the treatment of ARS

Daniel B Hall · Extend Biosciences (United States) · funded by National Institutes of Health

$300k

2017–2019 · research · R43

Long-acting ghrelin for the treatment of ARS

Daniel B Hall · Extend Biosciences (United States) · funded by National Institutes of Health

$300k

2017–2020 · research · R44

Long-acting ghrelin for the treatment of cancer cachexia

Tarik Soliman · Extend Biosciences (United States) · funded by National Institutes of Health

$1.4MRegulation of Appetite and Obesity

2017–2019 · research · R44

Long-acting ghrelin for the treatment of cancer cachexia

Tarik Soliman · Extend Biosciences (United States) · funded by National Institutes of Health

$832.9kRegulation of Appetite and Obesity

2017–2019 · research · R43

Ultralong-acting insulin for diabetes

Tarik Soliman · Extend Biosciences (United States) · funded by National Institutes of Health

$350kDiabetes Management and Research

2017–2020 · research · R44

Long-acting ghrelin for the treatment of cancer cachexia

Tarik Soliman · Extend Biosciences (United States) · funded by National Institutes of Health

$2 084

2015–2020 · research · R44

Long-acting PTH for hypoparathyroidism

Laura M Hales · Extend Biosciences (United States) · funded by National Institutes of Health

$1.9MThyroid and Parathyroid Surgery

2015–2023 · research · R44

Long-acting PTH for hypoparathyroidism

Laura M Hales · Extend Biosciences (United States) · funded by National Institutes of Health

$2MThyroid and Parathyroid Surgery

2015–2022 · research · R44

Long-acting PTH for hypoparathyroidism

Laura M Hales · Extend Biosciences (United States) · funded by National Institutes of Health

$1MThyroid and Parathyroid Surgery